The use of Laboratory for Cell and Gene Medicine resources must be consistent with Stanford's mission to develop innovative cell and gene based therapies for treatment of pediatric and adult patients with incurable disease. LCGM provides process development, regulatory affairs and quality systems expertise to support translating cell and gene therapies to the clinic.